Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 20/20 | 0.59 |
| ▸ | ADRB1 | P08588 | 15/20 | 0.59 |
| ▸ | MLNR | O43193 | 1/20 | 0.59 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.59 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.59 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.59 |
| ▸ | DRD1 | P21728 | 1/20 | 0.59 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.59 |
| ▸ | HTR2A | P28223 | 1/20 | 0.59 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.59 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.59 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.59 |
| ▸ | MC3R | P41968 | 1/20 | 0.59 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.59 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.59 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.59 |
| ▸ | GHSR | Q92847 | 1/20 | 0.59 |
| ▸ | ADRB3 | P13945 | 15/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL925689 | 1.00 | ADRB2 (0.59) | ADRB2ADRB1MLNRNR1I2ABCB11 | |
| SCHEMBL928498 | 1.00 | ADRB2 (0.59) | ADRB2ADRB1MLNRNR1I2ABCB11 | |
| SCHEMBL23014462 | 1.00 | ADRB2 (0.59) | ADRB2ADRB1MLNRNR1I2ABCB11 | |
| SCHEMBL15614731 | 0.94 | ADRB2 (0.54) | ADRB2ADRB1MLNRNR1I2ABCB11 | |
| SCHEMBL2563406 | 0.90 | ADRB2 (0.47) | ADRB2ADRB1MLNRNR1I2ABCB11 | |
| SCHEMBL28471346 | 0.88 | ADRB2 (0.49) | ADRB2ADRB1MLNRNR1I2ABCB11 | |
| SCHEMBL2586701 | 0.86 | ADRB2 (0.50) | ADRB2ADRB1MLNRNR1I2ABCB11 | |
| SCHEMBL925085 | 0.86 | ADRB2 (0.50) | ADRB2ADRB1MLNRNR1I2ABCB11 | |
| SCHEMBL15614682 | 0.86 | ADRB2 (0.45) | ADRB2ADRB1SLC6A2HTR2ASLC6A4 | |
| SCHEMBL5429959 | 0.84 | ADRB3 (0.41) | ADRB2ADRB1MLNRNR1I2ABCB11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050075394-A1 | Phenethanolamine derivatives for treatment of respiratory diseases | GLAXO GROUP LIMITED (GB) | 2005-04-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050075394-A1 | Phenethanolamine derivatives for treatment of respiratory diseases | PHOSPHO1, PNMT, PEBP1 | ADRB2 89/4885ADRB1 192/4885MLNR 988/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.